Oncology Central

AACR 2018: highlights and the biggest news headlines

0
Keep checking back throughout the conference, we will be updating this article with the biggest news headlines from the American Association for Cancer Research (AACR) Annual Meeting 2018 (April 14–18, IL, USA). Highlights include:
  • Positive data announced for KEYTRUDA® in adjuvant melanoma
  • KEYTRUDA scores big again in NSCLC Phase III KEYNOTE-189 study
  • Pembrolizumab and chemotherapy combo doubles survival in metastatic lung cancer
  • Promising immunotherapy strategy discovered for stage I–III NSCLC patients

KEYTRUDA scores big again in NSCLC Phase III KEYNOTE-189 study

Details of the KEYNOTE-189 study have been announced by Merck (known as MSD outside the United States and Canada).

To view restricted content, please:
Share:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.